Nanjing Well Pharmaceutical Co Ltd (603351) — Cash Flow Quality Index
Nanjing Well Pharmaceutical Co Ltd (603351) has a Cash Flow Quality Index of 1.68x as of September 2025. Operating cash flow of CN¥69.51 Million exceeds net income of CN¥41.30 Million, indicating high earnings quality where cash backs reported profits. Also explore how large is Nanjing Well Pharmaceutical Co Ltd's balance sheet for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Nanjing Well Pharmaceutical Co Ltd Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for Nanjing Well Pharmaceutical Co Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 603351 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Nanjing Well Pharmaceutical Co Ltd (2014–2024)
Year-by-year earnings quality comparison for Nanjing Well Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see 603351 market cap.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.53x | CN¥221.79 Million | CN¥145.21 Million | ▲ +38.6% |
| 2023 | 1.10x | CN¥120.24 Million | CN¥109.11 Million | ▼ -4.5% |
| 2022 | 1.15x | CN¥108.99 Million | CN¥94.43 Million | ▲ +1101.9% |
| 2021 | -0.12x | CN¥-11.54 Million | CN¥100.15 Million | ▼ -112.4% |
| 2020 | 0.93x | CN¥93.30 Million | CN¥100.45 Million | ▼ -8.2% |
| 2019 | 1.01x | CN¥129.69 Million | CN¥128.11 Million | ▲ +77.5% |
| 2018 | 0.57x | CN¥63.76 Million | CN¥111.81 Million | ▼ -14.0% |
| 2017 | 0.66x | CN¥71.27 Million | CN¥107.44 Million | ▼ -61.9% |
| 2016 | 1.74x | CN¥128.18 Million | CN¥73.71 Million | ▲ +30.2% |
| 2015 | 1.34x | CN¥81.14 Million | CN¥60.73 Million | ▼ -19.7% |
| 2014 | 1.66x | CN¥74.62 Million | CN¥44.83 Million | — |